Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Single Fraction Radiation Therapy (SFRT) at Roswell Park Cancer Institute for Select Patients With Early Stage Breast Cancer

NCT01754519 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT01754519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01754519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Single Fraction Radiation Therapy (SFRT) at Roswell Park Cancer Institute for Select Patients With Early Stage Breast Cancer
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2013
Completion date
August 31, 2015
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, estrogen receptor negative, estrogen receptor positive, her2/neu negative, invasive cribriform breast carcinoma, invasive ductal carcinoma, not otherwise specified, lobular breast carcinoma in situ, mucinous breast carcinoma, papillary breast carcinoma, progesterone receptor positive, stage i breast cancer, stage ii breast cancer, stage iiia breast cancer, stage iiic breast cancer, tubular breast carcinoma